These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22286022)

  • 1. The vasohibin family: Novel regulators of angiogenesis.
    Sato Y
    Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vasohibin family: a novel family for angiogenesis regulation.
    Sato Y
    J Biochem; 2013 Jan; 153(1):5-11. PubMed ID: 23100270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vasohibin-1 for more than angiogenesis inhibition?
    Sato Y
    J Biochem; 2011 Mar; 149(3):229-30. PubMed ID: 21217147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-like 4 and vasohibin 1: two endothelium-produced negative regulators of angiogenesis with distinctive roles.
    Sato Y
    Eur Cytokine Netw; 2009 Dec; 20(4):220-4. PubMed ID: 20167561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion.
    Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y
    J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
    Sato Y; Sonoda H
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
    Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
    PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible action of vasohibin-1 as an inhibitor in the regulation of vascularization of the bovine corpus luteum.
    Shirasuna K; Kobayashi A; Nitta A; Nibuno S; Sasahara K; Shimizu T; Bollwein H; Miyamoto A
    Reproduction; 2012 Apr; 143(4):491-500. PubMed ID: 22367587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
    Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
    Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on endogenous inhibitors of angiogenesis.
    Sato Y
    Endothelium; 2006; 13(2):147-55. PubMed ID: 16728331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor as an angiogenic factor.
    Nico B; Mangieri D; Benagiano V; Crivellato E; Ribatti D
    Microvasc Res; 2008 Mar; 75(2):135-41. PubMed ID: 17764704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of angiogenesis and remodelling of the microvasculature.
    Silvestre JS; Lévy BI; Tedgui A
    Cardiovasc Res; 2008 May; 78(2):201-2. PubMed ID: 18339645
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
    Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
    Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.
    Kimura H; Miyashita H; Suzuki Y; Kobayashi M; Watanabe K; Sonoda H; Ohta H; Fujiwara T; Shimosegawa T; Sato Y
    Blood; 2009 May; 113(19):4810-8. PubMed ID: 19204325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.
    Shibuya T; Watanabe K; Yamashita H; Shimizu K; Miyashita H; Abe M; Moriya T; Ohta H; Sonoda H; Shimosegawa T; Tabayashi K; Sato Y
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1051-7. PubMed ID: 16528006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.